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ABSTRACT 
Background: People with PD who exhibit freezing of gait (FOG) also exhibit poor balance 
compared to those who do not freeze. However, balance is a broad construct that can be 
subdivided into subdomains that include dynamic balance (gait), anticipatory postural 
adjustments (APAs) & gait initiation, postural sway in stance, and automatic postural responses 
(e.g., reactive stepping). Few studies have provided a robust investigation on how each of these 
domains is impacted by FOG, and no studies have compared balance across groups while 
rigorously controlling for disease severity.  
Methods: Structural equation modeling was used to evaluate the relationships between FOG 
and balance domains constructed as latent variables and controlling for disease severity. 
Domains included: dynamic balance (gait), APAs, postural sway, and reactive stepping. Models 
were run relating domains to both the presence and severity of FOG. 
Results: Latent variables reflecting domains of Gait and APAs, but not postural sway or reactive 
stepping, were significantly related to the severity of FOG. Models for presence of FOG showed 
the same results, as Gait and APAs, but not postural sway or reactive stepping, were related to 
presence of FOG.  
Conclusion: These results are consistent with hypotheses that balance deficits in people with 
PD who freeze are most pronounced in gait and anticipatory postural adjustments. Reactive 
stepping and postural control domains are less effected. These findings suggest that 




Freezing of gait (FOG) has substantial negative impact on quality of life in people with 
Parkinson’s disease (PD) and is inadequately controlled by pharmacological, rehabilitative, or 
surgical treatments[1]. FOG is closely linked to falls [2] and, like falls, is a transient symptom 
that occurs more frequently under certain circumstances (e.g., while turning, stressed, etc.[1]). 
Determining which specific balance and/or gait characteristics are impaired in people with FOG 
may provide a deeper understanding of potential mechanisms of FOG and may facilitate 
identification of rehabilitative targets for FOG.  
Previous studies have identified a robust relationship between the postural instability and 
gait dysfunction (PIGD) phenotype and FOG (e.g. [3]). However, postural instability and gait 
represents a broad and complex suite of abilities. Mancini, Nutt and Horak (2019) proposed four 
domains of balance, each of which are affected in PD, including balance during stance (i.e., 
postural sway), automatic postural responses, anticipatory postural adjustments (APAs), and 
dynamic balance during walking (i.e., gait)[4]. Recent studies have measured individual 
domains of balance in PD participants who do and do not freeze to facilitate a better 
understanding of the relationship between FOG and these specific signs (e.g.[5]). In 2018, 
Bekkers & colleagues conducted a narrative review to consolidate results of these studies. 
While results were markedly variable, weight shifts (APAs) and dynamic balance (i.e., gait), 
were consistently worse in people with PD and FOG compared to whose without FOG, while 
reactive postural adjustments and static postural control (i.e., quiet stance) were not typically 
different across these groups[6]. 
However, this literature has several limitations. First, each study typically measured 
balance outcomes in a single outcome or domain, making across-domain comparisons difficult. 
Second, studies were of relatively small samples (typically 10 and 20 participants per group), 
limiting generalizability of findings. Third, outcomes were assessed in freezing and non-freezing 
groups based on the presence of self-identified FOG symptoms. While this is a standard and 
commonly used approach, categorizing individuals into those who do and do not freeze can be 
challenging, especially considering that patients with PD often present with cognitive 
disturbances and may not be aware of FOG symptoms. Relating mobility outcomes to a 
continuous, objective measure of FOG may provide more sensitive and reliable relationships to 
balance domains. Fourth, FOG becomes more common later in the course of PD. Therefore, 
controlling for disease severity is critical to reduce the chance of parkinsonism severity 
confounding the relationship between FOG and posture and gait outcomes. Indeed, Bekkers et 
al. indicated that only 3 of the 30 studies included in the review controlled for PD severity[6].  
The purpose of the current study is to determine the relationship between both the 
presence and severity of FOG and specific, objectively defined domains of balance, accounting 
for disease severity. This topic is relevant for at least two reasons. First, it is plausible that there 
may be a direct relationship between balance and FOG episodes, such that poor balance may 
contribute to precipitation of a FOG event. If so, interventions aimed at improving relevant 
aspects of balance and/or gait may reduce FOG frequency. Second, characterizing which 
aspects of balance are related to FOG severity can provide a deeper understanding of the 
progression and occurrence of FOG. Based on previous work[6], we hypothesized that 
outcomes related to gait (measured primarily as pace and variability) and anticipatory postural 




Participant characteristics are shown in Table 1. 144 participants were recruited through 
physician referral at OHSU, local patient support groups, and fliers placed throughout the 
community. Inclusion criteria were: aged 50–90 years, ability to stand and walk unassisted, 
meet Brain Bank Criteria for idiopathic PD[7] and six weeks of stable medications. Exclusion 
criteria were: major musculoskeletal or peripheral disorders that could impact balance or gait 
and any non-PD neurological disorders and inability to follow instructions. The present work is a 
secondary analysis of baseline data collected as part of a clinical trial (Clinical Trials.gov 
NCT02231073 and NCT02236286), as well as additional, cross-sectionally collected data. 
Portions of these data have been examined previously without a focus on FOG [8, 9]. Also, a 
freezing/non-freezing comparison has been conducted with a portion (n=56, FOG-26, non-FOG- 
30) of the current dataset [10]. However, in addition to the smaller sample, the analyses and 
focus of this previous manuscript were distinct from the current report.  
 
Procedures 
Clinical scales were administered while subjects were in their practical Off state (at least 
12 hours after their last dose of Levodopa), and included: Movement Disorder Society-
sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)[11], the 
Activities-specific Balance Confidence scale (ABC-scale)[12], and the Montreal Cognitive 
Assessment (MoCA)[13].  
Motor tasks were then performed to characterize the following domains: Gait, APAs, 
Reactive Stepping, and Postural Sway. Data were collected via eight wearable, inertial sensors 
(Opals, APDM). The sensors were placed on both feet, shins, wrists, sternum and the lumbar 
region. Most motor tasks were collected while undergoing the Mini-Balance Evaluation System 
Test (Mini-BESTest)[8]. The data used to quantify performance in each domain are described 
below and shown in Figure 1a. Details on the algorithms used to calculate each outcome from 
wearable sensors can be found here[8, 14]. 
Dynamic balance (Gait): Subjects walked at a comfortable pace continuously between 
two lines 25 feet (7.62m) apart for 2 min. From this task, stride length, stride length variability 
(quantified as standard deviation), swing time, swing time variability, step duration asymmetry 
(calculated as the natural log of the ratio of left to right step duration, with the smaller of the two 
values as the numerator), and foot strike angle (in sagittal plane) were calculated[14]. Although 
by no means comprehensive in capturing all components of gait, these outcomes were chosen 
to represent aspects of gait previously suggested to be related to FOG[1, 15, 16] (see also 
“Limitations”, point two). 
APAs & Gait initiation: APA outcomes were derived from the step initiation phase (prior 
to gait) of the Instrumented Stand and Walk test[17]. As such, these outcomes were derived 
from a single trial per participant. After 30s of quiet standing, participants began walking at their 
comfortable speed[8].  A template was used to achieve consistent foot placement (10cm 
between heels and 30° outward rotation of feet). Specific outcomes were: peak medio-lateral 
APA, peak anterior-posterior APA, angle of foot at first foot strike, first step latency[8]. 
Reactive stepping: Postural responses to external perturbations were quantified with the 
backward Push and Release test within the MiniBESTest[18]. Standing subjects leaned against 
the tester’s hands just beyond their backward base of support. They were instructed to do 
whatever was necessary to regain balance, including taking steps, when the tester quickly 
removed support. As with APAs, only one trial was included for analysis. We chose only to 
include data from one reactive stepping trial because performance on reactive stepping can 
change considerably with repeated exposures (especially early in the exposures[19]). The first 
exposure is most likely to reflect participants’ most natural response. Outcomes to quantify 
reactive stepping were: first step latency, first step length, and MiniBESTest score (0, 1, or 2) on 
the backward reactive step item. MiniBESTest score on the forward reactive stepping item was 
also included. Instrumented outcomes (step latency, length, etc.) for forward Push and Release 
were not calculated as the algorithms for this movement have not yet been validated. 
Postural Sway: Quiet stance data (eyes open, firm surface) were collected for 30sec. 
During this period, jerk and root mean square of acceleration (medio-lateral and anterior-
posterior axes) were calculated[20]. 
To provide an objective measure of FOG severity, acceleration data were collected from 
the left and right shins during a turning in place test. Participants were required to turn in place, 
alternating 360° turn to the right and left for 60 seconds as quickly as safely possible [21]. FOG 
ratio was calculated as the square of the total power in the frequency band corresponding with 
FOG (3.5–8 Hz) divided by the square of the total power in the locomotion band (0.5–3 Hz). This 
calculation was conducted separately for the left and right shins, and then averaged across legs 
[21]. Higher FOG ratio scores indicate greater FOG severity.  FOG ratio has been validated 
against gold standard FOG severity video observation by trained movement disorders 
neurologists[21]. Finally, we assessed presence of FOG, indicated as scoring a 1 on question 1 
of the New FOG Questionnaire (NFOGQ) “Did you experience ‘freezing episodes’ over the past 
month”[22]. 
Statistical approach: 
Analyses were performed using Stata 15.1/IC. Structural equation modeling was used to 
evaluate the relationships between FOG (measured continuously with the FOG Ratio and 
dichotomously [absent-0; present-1] from the NFOGQ) and the balance and gait domains 
constructed as latent variables, controlling for disease duration and severity (MDS-UPDRS Part 
III). In rare cases (n=8), the participant noted 0 on the NFOGQ, but freezing episodes were 
observed during testing, and confirmed by an expert neurologist reviewing video. In these 
cases, this individual was placed in the FOG group. First, the latent variable measurement 
models were evaluated with a general confirmatory factoring approach. Issues with 
convergence were evaluated to inform remediation. The only instance of nonconvergence 
resulted from a Heywood case for the measurement model of Postural Sway. Maximum 
likelihood estimates produced a negative residual variance for the “sway area” indicator within 
the Postural Sway latent variable. Therefore, this indicator was removed from the measurement 
model to abet convergence. 
Estimation of measurement models  
We initially examined the measurement models to determine whether the observed 
variables measured their respective latent constructs. Models were performed using full 
information maximum likelihood to handling missing data. The fit indices reported beyond the χ2 
test of model fit include Comparative Fit Index (CFI), Root Mean Squared Error of 
Approximation (RMSEA), CD (Coefficient of Determination), and Square Root Mean Residual 
(SRMR; reported where possible when no missing values exist.) The results from the 
measurement models are reported in Supplemental Tables 2-5. The models for APA and 
Reactive Stepping had good initial fit, but the step latency metrics in these models (first step, 
and reactive stepping, respectively) had weaker loadings and conceptually could be considered 
distinct in these domains. Thus, they were removed from the model. This meant that the final 
models for APA and Reactive Stepping were just identified and could not be evaluated with fit 
statistics based on the saturated model. However, the loadings for these models were in the 
expected directions and statistically significant. The models for Gait and Postural Sway did not 
fit well statistically or descriptively. To prevent suspect inferences from the full structural model, 
these models were modified to improve fit[23]. For Gait, step asymmetry did not load 
significantly, p = .364, was removed. We also added an error covariance between the measures 
of variability of Gait. After these modifications, the model did not fit well statistically, but 
descriptive measures of fit indicated acceptable-to-good fit (CFI = .965, SRMR = .051). For 
Postural Sway the RMS and Jerk values were natural log transformed and an error covariance 
was added between the RMS indicators. After this modification, the model did not fit well 
statistically, but most descriptive measures of fit indicated acceptable-to-good fit (CFI = .944, 
SRMR = .035). 
Second, after establishing the fit of each measurement model, the full structural model 
was specified—once with FOG measured continuously across all participants and once with 
FOG measured dichotomously as freezers or non-freezers. To further measure the robustness 
of these findings, bootstrapping was performed using 500 random resamples with replacement. 
Bootstrapped standard errors (SEs) and bias-corrected (BC) confidence intervals (CIs) were 
computed to make inferential decisions within the context of bootstrapping for comparison to the 
observed information matrix (OIM) SEs and normal-theory-based CIs. The continuous measure 
of FOG severity (FOG ratio), was right skewed, and some participants were shown to be 
potential outliers. To help control for these potential effects, FOG-ratio data were log-
transformed prior to running our primary analyses. However, because transformations can 
reduce interpretability of data, and to further investigate the robustness of findings, models were 
also run on original FOG ratio data. Finally, to provide a secondary assessment of the impact of 





Participant characteristics are shown in table 1. PD who experienced FOG had longer 
disease, p = 0.001, and more severe PD, p < 0.001, and performed worse on both the ABC, p < 
0.001, and MiniBESTest, p = 0.003. Age, levodopa equivalent daily dose, and MoCA were 
similar across groups, ps > 0.05. Notably, assessment of objective measures of Reactive 
Stepping was not possible from 13 people with FOG and 7 people without FOG as they 
experienced a fall without stepping, and measures of Postural Sway from 4 FOG and 1 non-
FOG participant were not included as they could not stand for 30 seconds. 
 
Across-group differences in gait outcomes 
Means and standard deviations of all outcomes in PD with and without FOG, as well as 
simple uncorrected across group assessments are provided in Supplemental Table 1, indicating 
people with FOG performed worse in the Gait and APA, but not Sway and Reactive stepping 
aspects of balance compared to people without FOG.   
FOG severity and balance domains 
Our primary analysis utilizing structural equation modeling showed similar results. Using 
OIM for SEs and normal-theory CIs, Gait, 95% CI[-.4377, -.0083], and APA, 95% CI[-.7601, -
.2498], were significantly and negatively related to the natural log of FOG severity (Table 2). 
That is, poorer natural log FOG ratio scores corresponded to worse gait and APA outcomes. 
Neither Postural Sway, 95% CI[-.1174, .3608], nor Reactive Stepping, 95% CI[-.2600, .2537], 
was significantly related to FOG severity. Bootstrapped analyses confirmed the significance of 
the Gait and APA domain findings. Using 500 resamples to compute bootstrapped SEs and BC 
CIs, both Gait, 95% CI[-.5939, -.0012] and APA 95% CI[-27.2058, -.0045] remained significantly 
and negatively related to the natural log of FOG severity.  
FOG status and balance domains 
Using OIM SEs and normal-theory CIs, Gait, 95% CI[-0.2867, -0.1259] , and APA, 95% 
CI[-0.3727, -0.1461], but not Postural Sway,  95% CI[-0.1059, 0.0673], or Reactive Stepping,  
95% CI[-0.1922, 0.0068], were significantly related to FOG status. Using bootstrapped SEs and 
BC CIs, both Gait, 95% CI -0.2755, -0.0038], and APA, 95% CI[-0.6135, -0.0044], remained 
significantly and negatively related to FOG status.  
For additional information regarding relationships between covariates and latent 
constructs for OIM and bootstrapped analyses, see Supplemental Tables 6 (for relationship to 
FOG severity) & 7 (for relationship to FOG status). Further, relationships between covariates 
and latent constructs with untransformed data were generally consistent with transformed 
results, and can be found in Supplemental Tables 8 and 9. 
Finally, although not a primary outcome of the study, NFOGQ total score and FOG ratio 
in the FOG group were shown to be significantly correlated (Spearman’s Rho = 0.285, p=0.024; 
See supplemental Figure 1).  
 
DISCUSSION 
Our findings suggest that, when controlling for disease severity, dynamic balance (i.e., 
gait) and gait initiation (i.e., APAs & first step), were associated with the severity and presence 
of FOG, whereas automatic postural stepping responses and postural sway were not (see 
schematic in Figure 1b). Notably, the analysis used in this study had 4 important features: 1) 
data were included to capture four established and theoretically grounded balance domains[24], 
each containing 4 to 6 objectively measured outcomes, 2) a relatively large sample of 
participants (n=144 in their Off state) was included, 3) models were included for both 
dichotomous (presence or absence of FOG) and continuous (FOG severity) outcomes, and 4) 
the models were corrected for PD disease severity and duration. The relationship between FOG 
and each of the four balance domains are discussed in turn. 
The finding that gait deficits are related to the presence and severity of FOG is 
consistent with previous work. Several aspects of gait are altered in freezers compared to non-
freezers, even when excluding actual freezing events[15]. The underlying mechanism linking 
deficits in these continuous gait outcomes and transient FOG outcomes is not fully understood. 
Recent work suggests that gait may be more attentionally demanding in people who freeze 
compared to non-freezers, thus increasing variability of gait [1]. Indeed, dynamic balance 
activities including walking indicate that PD who freeze exhibit more activity of the frontal cortex 
than those who do not freeze[25]. Further, these increased demands on the cortico-basal 
ganglia system may place the individual closer to a freezing event, which could be triggered by 
a cognitive, affective, or motor conflict[26], underpinned by a de-coupling of the cortico-thalamic 
system [27].  
APAs have been related to freezing prior to gait initiation or “start hesitation”. Although 
failure of gait initiation is a complex problem, it may be precipitated by abnormal APA 
production. More specifically, start hesitation, and the leg trembling that sometimes 
accompanies it, could reflect an uncoupling of the weight shift prior to the step (APA) and the 
step-related leg movement[28]. Consistent with the current report, some[29], although not 
all[30], recent work has shown people who freeze to exhibit smaller APAs than their non-
freezing counterparts. The smaller APAs in PD who freeze may be related to brainstem and 
supplementary motor cortex dysfunction[16], as brainstem regions including the pontomedullary 
reticular formation are critical for APA production as well as the subsequent step[31]. The 
current study suggests that in addition to smaller APAs, people with PD who freeze also exhibit 
worse first voluntary steps, underscoring the functional significance of altered APAs. Notably, 
altered APA size has also been suggested to be a compensatory strategy for those who freeze. 
Schlenstedt and colleagues demonstrated that while APAs were smaller in people who freeze, 
they were unlikely to have been caused by poor APA production. Instead, the smaller APAs 
may have been caused by increased hip abductor co-contraction, possibly a compensatory 
strategy in those who freeze [29].  
Reactive postural control was not related to the presence or severity of FOG. These 
results are consistent with a growing body of work that suggests postural responses to external 
perturbations are not significantly different in people who do and do not freeze[5, 32, 33]. 
Further, although both postural instability and FOG symptoms become more pronounced as PD 
progresses, a substantial proportion of people with PD who freeze have similar postural control 
performance to people who do not freeze[3]. Together, this work suggests that reactive postural 
control may be at least partially a distinct phenomenon to FOG and perhaps more linked to the 
progression of PD. Indeed, as shown in supplemental tables 7 and 8, disease severity 
(measured as MDS-UPDRS III) was a significant covariate for reactive postural control in both 
the “presence” and “severity” of FOG models. However, additional studies, with carefully 
selected participants, matched across different aspects of FOG and postural instability (See for 
example [32]) will be needed to fully clarify the relationship between these complex and 
multifaceted symptoms. 
Postural sway was also not related to FOG in our cohort. Although data on this topic is 
mixed, previous work suggests that people with FOG do not consistently exhibit altered static 
postural control compared to non-freezers[6]. Interestingly however, a few studies have 
indicated that under complex conditions, such as dual-tasking or when sensory integration is 
challenged, freezers may exhibit altered sway characteristics (e.g.[29]). In the current study, 
sway was evaluated only with in the eyes-open, firm surface condition, limiting our ability to 
clarify this potential relationship.  
In the current analysis, we evaluated the relationship among four balance domains and 
both the presence of FOG and the severity of FOG. Given the transient nature of FOG and 
challenges in dichotomizing PD patients into those who do and do not freeze, we hypothesized 
that continuous outcomes may be more able to capture relationships between FOG and 
outcomes. However, we observed that FOG presence and FOG severity (measured as FOG 
ratio) were similarly related to our balance domains. This may be a reflection of the relatively 
large dataset used in this study, as more continuous outcomes may become more important for 
prediction as the sample becomes smaller. Regardless, this finding provides circumstantial 
evidence of the relevance of the FOG ratio to quantify severity of FOG. Establishing quantitative 
outcomes of FOG severity is critical for tracking progression of FOG and evaluating the effect of 
interventions on this outcome.  
 
LIMITATIONS 
Several limitations should be noted. First, we acknowledge that while several objective 
outcomes were included for each domain, some outcomes (e.g., turning, sensory re-weighting, 
etc.) were not evaluated. Second, we included only one latent variable for each balance domain, 
despite the fact that each may be broken into several sub-domains. For example, “gait” is quite 
broad, and indicators chosen here were not comprehensive in capturing all aspects gait. In fact, 
it partially is because of this variability across gait outcomes (and also in other domains) that we 
chose to be conservative with the number of indicators per domain, focusing specifically on 
those that have been suggested to be related to FOG (e.g. stride length, variability, and 
asymmetry). Therefore, some potentially interesting outcomes were excluded. An investigation 
into the relationship between FOG and subdivisions of each domain (with expanded number of 
outcomes) is warranted; however such an analysis was outside the scope of the current 
manuscript. Third, for the reactive stepping domain, data from 13 people with and 7 without 
FOG were excluded because of falls. For the sway domain 4 people with and 1 without FOG 
were excluded due to an inability to stand for 30 seconds. Therefore, our analysis did not 
account for a small subset of severe participants. Fourth, data were collected in the practical Off 
state medication. Given that levodopa may have variable effects on posture and gait [34], 
addition of medication could also impact these outcomes as well as the relationship between 
FOG and such outcomes. Fifth, we acknowledge that while inertial sensors are commonly used 
for gait and balance assessments, the reliability of these outcomes is, in some cases, variable. 
Specifically, while reliability of stride length and time, and their respective variability have been 
shown to be good to excellent with the use of inertial sensors (ICC>0.75), some of the tested 
outcomes (e.g. swing time), exhibit poor ICCs. Therefore, although we have no reason to 
believe that these measures would have been biased asymmetrically across groups, data 
should be interpreted with caution. Further, other devices, such as an instrumented walking mat, 
may have been able to provide more detailed or accurate spatial and asymmetry outcomes. 
Sixth, the FOG ratio is calculated during stepping in place, and therefore could biased it toward 
a relationship with stepping or gait outcomes. Two points somewhat lessen this concern: 1) 
FOG ratio has been shown to be related to FOG severity assessed via video-review[21], and 2) 
the presence of FOG model also showed a relationship to Gait. Nevertheless, this limitation is 
notable as it may have implications for development of rehabilitative approaches for different 
sub-types of FOG such as doorways and dual-tasking triggers.  Seventh, as noted in the 
methods section, while models for APA and Reactive Stepping fit well statistically and 
descriptively, models for Gait and Postural Sway did not fit well statistically. After adjusting the 
models, Gait and Postural sway did fit well descriptively, but not statistically. This lack of 
statistical fit could impact inferences. Lastly, it is possible that freezing events during initiation 
(start hesitation) or gait may have occurred, contributing to the relationship between FOG status 
and severity and gait/gait initiation. However, anecdotally, none of the participants exhibited 
freezing during gait or start hesitation during the tasks in question, reducing this concern.  
 
CONCLUSIONS  
 We observed that presence and severity of freezing of gait was related to impairments of 
dynamic balance (gait) and gait initiation (APAs), but not reactive or static balance in people 
with PD when Off medication. These findings provide further support for the idea that dynamic 
balance and weight shifting are often impacted in people with PD who experience FOG. These 
domains may be especially important rehabilitative targets to improve balance in PD with FOG.  
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Figure Captions 
Figure 1. Schematic of the model showing the four latent variable mobility domains (and their 
respective objective measures selected to constitute each domain) and their potential 
relationship to FOG. Shaded domains represent those which were significantly related to FOG 
accounting for disease severity and duration. Covariances for the relationships between the 







Table 1: Participant characteristics for people with PD who did (FOG+) 
and did not (FOG-) experience freezing of gait.  
FOG+ (n=64) FOG- (n=80) 
 
  Mean STD Mean STD p 
Male Gender (%) 44 68.80 49 61.3 0.384 
Age (y) 68.06 8.04 68.75 8.04 0.611 
Disease Duration (y) 7.8 5.4 5.0 4.2 0.001 
LEDD  868.6 1355.0 609.3 416.8 0.176 
ABC (%) 73.75 17.57 85.79 13.00 0.000 
MDS-UPDRS 77.58 20.64 60.05 17.26 0.000 
MiniBESTest 17.19 5.40 19.68 4.08 0.003 
MoCA 25.49 3.78 25.99 3.06 0.400 
NFOGQ 12.10 7.09 -- -- -- 
FOG ratio* 2.64 6.03 0.68 0.76 0.001* 
LEDD: Levodopa Equivalent Daily Dose, ABC: Activities of Balance 
Confidence; MDS-UPDRS: Movement Disorders Society Unified 
Parkinson’s Disease Rating Scale, MoCA: Montreal Cognitive 
















Abbreviations for supplemental material:  
SD- Standard deviation; ML: Medio-Lateral; AP: Anterior-posterior; ROM: Range of Motion; 
MiniBESTest: Mini Balance Evaluation Systems Test; RMS: Root Mean Square; APA: 
Anticipatory Postural Adjustment; MDS-UPDRS III: Movement Disorders Society Unified 
Parkinson’s Disease Rating Scale, Part III; CFI: Comparative Fit Index; RMSEA: Root Mean 
Squared Error of Approximation; OIM: Observed Information Matrix; CI: Confidence Interval; 
CD: Coefficient of Determination; SE: Standard Error; LB/UB: Lower/ Upper bounds; Cov: 
Covariance; BS = Bootstrapped 
 
Table S1: Gait and balance outcomes in each domain (Gait, APA, reactive stepping, and 
postural sway). Performance on each outcome are shown for people who do (FOG+) and 
do not (FOG-) exhibit FOG. Across group assessments of means are also provided. 
 
 FOG+ (n=64) FOG- (n=80)  
  Mean STD Mean STD p 
Gait      
Stride Length (m) .923 .201 1.065 .139 < .001* 
Stride Length (SD) 0.0568 .024 0.0476 .017 .008* 
Swing Time (% gait cycle) 38.102 2.176 39.048 1.951 .007* 
Swing Time (SD) 1.3567 .688 0.9814 .306 < .001* 
Step Duration Asymmetry (%) -.027 .027 -.022 .023 .202 
Foot Strike Angle (deg) 10.420 5.482 14.127 4.508 < .001* 
APA      
Peak ML (m) .030 .013 .037 .015 .005* 
Peak AP (m) .034 .018 .046 .024 .001* 
1st Step ROM (deg) 28.011 9.819 34.011 5.705 < .001* 
1st voluntary step latency (s) .710 .295 .700 .209 .813 
Reactive stepping      
1st reactive step latency (s) .138 .060 .159 .106 .099 
1st reactive step length (m) .171 .113 .208 .112 .070 
MiniBESTest Compensatory (Forward) 1.125 .724 1.25 .606 .261 
MiniBESTest Compensatory (Backward) 1.281 .654 1.438 .548 .121 
Postural sway      
Sway Area .093 .063 .106 .077 .312 
Jerk ML 1.893 2.754 1.961 2.489 .881 
Jerk AP 2.516 2.805 2.031 1.862 .334 
RMS ML .062 .024 .068 .025 .225 
RMS AP .081 .034 .080 .037 .908 






Table S2. Unstandardized Results from Measurement Model for APA 
χ2(.) = ., p = ., CFI = 1.00, RMSEA < .001, CD = .486. 
 Coef. OIM SE z p 95% LB 95% UB 
Peak ML APA       
     Loading (λ) .0081 .0025 3.28 .001 .0032 .0129 
     Intercept (ν)  .0334 .0013 26.39 < .001 .0309 .0359 
     Variance (θ) .0002 .00004   .0001 .0002 
Peak AP APA       
     Loading (λ) .0111 .0035 3.15 .002 .0042 .0180 
     Intercept (ν)  .0408 .0020 20.75 < .001 .0369 .0447 
     Variance (θ) .0004 .0001   .0003 .0006 
1st Step ROM       
     Loading (λ) 3.4133 1.1444 2.98 .003 1.1703 5.6564 
     Intercept (ν)  31.3446 .3919 45.31 < .001 29.9886 32.7006 
     Variance (θ) 57.2769 9.2833   41.6888 78.6938 
Note: Latent variable constrained to be standard normal. Model just identified; χ2 test of 
specified versus saturated model unavailable. Specified model significantly decreases misfit 
compared to null model, χ2(3) = 18.645, p < .001. 
Table S3. Unstandardized Results from Measurement Model for Reactive Stepping 
χ2(.) = ., p = ., CFI = 1.00, RMSEA < .001, CD = .829. 
 Coef. OIM SE z p 95% LB 95% UB 
First Step Length       
     Loading (λ) .0500 .0149 3.35 .001 .0207 .0792 
     Intercept (ν)  .1805 .0110 16.47 < .001 .159 .202 
     Variance (θ) .0111 .0016   .0083 .0148 
MiniBESTest Backward       
     Loading (λ) .5929 .1112 5.33 <.001 .3749 .8108 
     Intercept (ν)  1.1944 .0549 21.75 < .001 1.0868 1.3021 
     Variance (θ) .0829 .1223   .0046 1.4919 
MiniBESTest Forward       
     Loading (λ) .3127 .0713 4.39 <.001 .1729 .4524 
     Intercept (ν)  1.3681 .0498 27.45 < .001 1.2704 1.4657 
     Variance (θ) .2598 .0457   .1841 .3667 
Note: Latent variable constrained to be standard normal. Model just identified; χ2 test of 
specified versus saturated model unavailable. Specified model significantly decreases misfit 







Table S4. Unstandardized Results from Measurement Model for Gait 
χ2(4) = 18.11, p = .001, CFI = .965, SRMR = .051, RMSEA = .157, 90% CI [.088, .234], CD = 
.923. 
 Coef. OIM SE z p 95% LB 95% UB 
Stride Length       
     Loading (λ) .1709 .0121 14.08  < .001  .1471  .1947 
     Intercept (ν)  1.002 .015 65.86 < .001 .973 1.032 
     Variance (θ) .004 .002   .002 .008 
Stride Length (SD)       
     Loading (λ) -.0099 .0017 -5.69 < .001 -.0133 -.0065 
     Intercept (ν)  .052 .002 29.96 < .001 .048 .055 
     Variance (θ) .0003 .00004   .0003 .0004 
Swing Time       
     Loading (λ) 1.2131 .1656 7.33 < .001 .8886 1.5376 
     Intercept (ν)  38.631 .175 220.81 < .001 38.289 38.974 
     Variance (θ) 2.906 .360   2.279 3.704 
Swing Time (SD)       
     Loading (λ) -.4506 .0387 -11.63 < .001 -.5265 -.3747 
     Intercept (ν)  1.147 .045 25.39 < .001 1.058 1.235 
     Variance (θ) .089 .016   .063 .126 
Foot Strike       
     Loading (λ) 4.1213 .3785 10.89 < .001 3.3794 4.8633 
     Intercept (ν)  12.494 .440 28.42 < .001 11.632 13.355 
     Variance (θ) .029 .004   .022 .039 
Cov(e.Stride Length SD, e. 
Swing Time SD) 
.003 .001 4.69 < .001 .002 .004 















Table S5. Unstandardized Results from Measurement Model for Postural Sway 
χ2(1) = 12.70, p = .0004, CFI = .944, SRMR = .035, RMSEA = .290, 90% CI [.163, .443], CD = 
.745. 
 Coef. OIM SE z p 95% LB 95% UB 
ln(RMS AP)       
     Loading (λ) .2537 .0375 6.77 <.001 .1803 .3271 
     Intercept (ν)  -2.6021 .0334 -77.93 < .001 -2.6676 -2.5367 
     Variance (θ) .0906 .0159   .0643 .1277 
ln(RMS ML)       
     Loading (λ) .2521 .0355 7.10 < .001 .1826 .3217 
     Intercept (ν)  -2.7941 .0312 -89.45 < .001 -2.8553 -2.7328 
     Variance (θ) .0721 .0143   .0488 .1064 
ln(Jerk AP)       
     Loading (λ) .5510 .0767 7.19 < .001 .4008 .7013 
     Intercept (ν)  .4478 .0661 6.68 < .001 .3121 .5714 
     Variance (θ) .3046 .0670   .1979 .4686 
ln(Jerk ML)       
     Loading (λ) .5871 .0804 7.30 < .001 .4294 .7447 
     Intercept (ν)  .2349 .0709 3.31 .001 .0959 .3738 
     Variance (θ) .3540 .0742   .2348 .5337 
Cov(e.ln(RMS AP), e. 
ln(RMS ML)) 
.1611 .0601 2.68 .007 .0433 .2790 
Note: Latent variable constrained to be standard normal. 
 
Table S6. Relationships with Covariates from Continuous FOG (log-transformed) Model 
 Coef. OIM SE 95% LB 95% UB BS SE 95% LB 95% UB 
Postural Sway        
     MDS UPDRS 4.1734 1.8022 0.6411 7.7057 2.4829 0.0478 9.4377 
     Disease Duration -0.0615 0.5186 -1.0780 0.9549 0.6308 -1.4476 1.1207 
Reactive Stepping        
     MDS UPDRS -7.7257 2.0799 -11.8022 -3.6493 3.7364 -12.5881 -0.0948 
     Disease Duration -0.8917 0.5037 -1.8790 0.0955 0.5485 -2.1408 -0.0076 
     APAs 0.6055 0.1079 0.3941 0.8169 5.3682 -0.0235 28.5089 
     Gait 0.6056 0.0803 0.4482 0.7630 0.2526 0.0143 0.7861 
APAs        
     MDS UPDRS -9.0507 2.3068 -13.5719 -4.5294 63.7189 -20.4826 -0.2084 
     Disease Duration -1.7235 0.5153 -2.7335 -0.7136 13.8437 -101.6147 -0.0004 
     Gait 0.7221 0.0947 0.5365 0.9078 6.3648 -0.0024 2.8078 
Gait        
     MDS UPDRS -11.5630 1.6321 -14.7618 -8.3643 4.7737 -15.5013 -0.2863 
     Disease Duration -0.9318 0.4247 -1.7641 -0.0994 0.5347 -2.0551 0.0018 
MDS UPDRS         
     Disease Duration 32.5176 9.1637 14.5570 50.4781 8.7995 17.3227 51.1046 
     ln(FOG) 5.4929 2.3083 0.9688 10.0170 2.4998 0.8867 10.4119 
Disease Duration        
     ln(FOG) 2.7528 0.5752 1.6254 3.8801 0.7121 1.5909 4.5447 
Note: Relationships between latent variables and freezing outcomes are reported in the main 
text (significant relationships found between FOG ratio and Gait and APA but not Reactive 
Stepping or Postural Sway). See main-text Table 2 for details. Bootstrapping was performed 
with 500 resamples. Bias-corrected confidence intervals are reported after the BS SE. All 
coefficients reported are covariances. Bold font indicates 95% CI does not contain 0. The 
covariance between Postural Sway and APAs was not significant, so it was not included in the 
model.  
 
Table S7. Relationships with Covariates from Dichotomous FOG Model 
 Coef. OIM SE 95% LB 95% UB BS SE 95% LB 95% UB 
Postural Sway        
     MDS UPDRS 4.1499 1.7994 0.6232 7.6767 2.4303 0.0727 9.0278 
     Disease Duration -0.0276 0.5197 -1.0461 0.9910 0.6347 -1.4164 1.1905 
Reactive Stepping        
     MDS UPDRS -7.6841 2.0801 -11.7611 -3.6071 3.6753 -12.1304 -0.0601 
     Disease Duration -0.8787 0.5018 -1.8622 0.1049 0.5458 -2.1435 -0.0039 
     APAs 0.6337 0.1120 0.4141 0.8533 2.9684 -0.0277 1.8180 
     Gait 0.6009 0.0818 0.4406 0.7612 0.2462 0.0126 0.7688 
APAs        
     MDS UPDRS -9.9511 2.3479 -14.5529 -5.3492 38.0243 -18.7293 -0.0755 
     Disease Duration -1.8778 0.5388 -2.9340 -0.8217 7.0498 -4.8236 -0.0040 
     Gait 0.7732 0.0913 0.5943 0.9521 3.6028 0.0033 2.3208 
Gait        
     MDS UPDRS -11.6442 1.6323 -14.8434 -8.4450 4.8012 -15.4198 -0.1438 
     Disease Duration -0.9269 0.4250 -1.7600 -0.0938 0.5310 -2.1007 0.0010 
MDS UPDRS         
     Disease Duration 32.3602 9.1613 14.4044 50.3160 8.8672 16.4991 51.2422 
     Freezer (N/Y) 4.3777 0.9426 2.5303 6.2252 0.8062 2.9677 6.2052 
Disease Duration        
     Freezer (N/Y) 0.7108 0.2132 0.2929 1.1287 0.2027 0.3642 1.1241 
Note: Relationships between latent variables and freezing status are reported in the main text 
(significant relationships found between FOG status and Gait and APA but not Reactive 
Stepping or Postural Sway). See main-text Table 2 for details. Bootstrapping was performed 
with 500 resamples. Bias-corrected confidence intervals are reported after the BS SE. All 







Table S8. Relationships with Covariates from Continuous FOG Model without 
Transformations 
 Coef. OIM SE 95% LB 95% UB BS SE 95% LB 95% UB 
Postural Sway        
     MDS UPDRS 3.300 2.075 -.767 7.368 2.863 -.948 9.463 
     Disease Duration -.276 .587 -1.427 .876 .842 -1.813 1.194 
     FOG ratio .158 .405 -.635 .952 .745 -.734 2.319 
Reactive Stepping        
     MDS UPDRS -7.763 2.093 -11.865 -3.662 3.525 -12.406 -.091 
     Disease Duration -.918 .506 -1.909 .073 .552 -2.129 -.006 
     APAs .598 .108 .386 .810 8.929 -.035 38.214 
     Gait .605 .081 .447 .763 .232 .047 .779 
     FOG ratio -.570 .426 -1.406 .265 .523 -2.147 .039 
APAs        
     MDS UPDRS -8.910 2.330 -13.476 -4.344 92.722 -229.895 -.070 
     Disease Duration -1.681 .511 -2.683 -.680 18.092 -113.855 -.025 
     Gait .710 .098 .518 .902 9.957 -.008 44.726 
     FOG ratio -1.931 .425 -2.765 -1.097 30.506 -59.431 .001 
Gait        
     MDS UPDRS -11.507 1.645 -14.732 -8.282 4.164 -15.343 -.524 
     Disease Duration -.940 .424 -1.772 -.108 .496 -1.933 -.011 
     FOG ratio -1.164 .351 -1.852 -.477 .753 -3.571 -.020 
MDS UPDRS         
     Disease Duration 32.567 9.153 14.628 50.506 8.812 16.153 51.013 
     FOG ratio 21.659 7.377 7.201 36.116 11.077 5.530 57.650 
Disease Duration        
     FOG ratio 5.890 1.779 2.403 9.377 4.340 .251 18.757 
Note: Bootstrapping was performed with 500 resamples. Bias-corrected confidence intervals are 
reported after the BS SE. All coefficients reported are covariances. Bold font indicates 95% CI 
does not contain 0. The covariance between Postural Sway and APAs was not significant, so it 












Table S9. Relationships with Covariates from Dichotomous FOG Model without 
Transformations 
 Coef. OIM SE 95% LB 95% UB BS SE 95% LB 95% UB 
Postural Sway        
     MDS UPDRS 3.422 2.078 -.650 7.494 2.858 -.511 10.186 
     Disease Duration -.240 .583 -1.382 .902 .774 -1.696 1.106 
     FOG (N/Y) -.019 .047 -.111 .072 .051 -.138 .049 
Reactive Stepping        
     MDS UPDRS -7.684 2.088 -11.777 -3.591 3.551 -12.211 -.112 
     Disease Duration -.904 .504 -1.891 .084 .557 -2.260 -.004 
     APAs .633 .1112 .414 .853 4.132 -.022 44.200 
     Gait .601 .082 .440 .761 .235 .045 .801 
     FOG (N/Y) -.093 .051 -.193 .007 .061 -.222 .001 
APAs        
     MDS UPDRS -10.023 2.349 -14.627 -5.419 48.476 -520.160 -.149 
     Disease Duration -1.869 .538 -2.924 -.815 8.816 -93.144 -.014 
     Gait .773 .091 .594 .952 4.988 .008 50.785 
     FOG (N/Y) -.259 .058 -.372 -.145 1.396 -12.483 -.004 
Gait        
     MDS UPDRS -11.555 1.645 -14.779 -8.332 4.516 -15.799 -.318 
     Disease Duration -.934 .425 -1.767 -.102 .525 -1.864 .001 
     FOG (N/Y) -.207 .041 -.287 -.126 .080 -.281 -.009 
MDS UPDRS         
     Disease Duration 32.487 9.146 14.561 50.413 8.946 15.936 51.014 
     FOG (N/Y) 4.376 .941 2.532 6.220 .802 2.974 6.131 
Disease Duration        
     FOG (N/Y) .709 .213 .292 1.127 .201 .358 1.122 
Note: Bootstrapping was performed with 500 resamples. Bias-corrected confidence intervals are 
reported after the BS SE. All coefficients reported are covariances. Bold font indicates 95% CI 
does not contain 0. 
 
  
Supplemental Figure 1: Correlation between FOG ratio and NFOGQ total score. A significant 
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